Lipe & Dalton Merck & Co., Inc. Transaction History

Lipe & Dalton

$198 Million
Q3 2024

A detailed history of Lipe & Dalton transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lipe & Dalton holds 11,907 shares of MRK stock, worth $1.21 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

11,907

Previous 11,929 0.18%

Holding current value

$1.21 Million

Previous $1.48 Million 8.46%

% of portfolio

0.68%

Previous 0.79%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$111.15 - $128.97 $2,445 - $2,837	-22 Reduced 0.18%	11,907 $1.35 Million
Q2 2024 Aug 02, 2024	BUY	$123.8 - $132.96 $247 - $265	2 Added 0.02%	11,929 $1.48 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $11,550 - $13,458	102 Added 0.86%	11,927 $1.57 Million
Q4 2023 Jan 30, 2024	BUY	$100.18 - $109.02 $200 - $218	2 Added 0.02%	11,825 $1.29 Million
Q3 2023 Nov 03, 2023	BUY	$102.95 - $114.33 $102 - $114	1 Added 0.01%	11,823 $1.22 Million
Q2 2023 Jul 26, 2023	BUY	$108.61 - $118.38 $108 - $118	1 Added 0.01%	11,822 $1.36 Million
Q1 2023 May 02, 2023	SELL	$102.94 - $114.86 $15,441 - $17,229	-150 Reduced 1.25%	11,821 $1.26 Million
Q4 2022 Feb 03, 2023	BUY	$87.44 - $112.11 $87 - $112	1 Added 0.01%	11,971 $1.33 Million
Q3 2022 Nov 07, 2022	BUY	$84.53 - $94.96 $291,628 - $327,612	3,450 Added 40.49%	11,970 $1.03 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $250,469 - $283,920	3,000 Added 54.35%	8,520 $777,000
Q1 2022 Apr 26, 2022	BUY	$73.51 - $82.4 $36,755 - $41,200	500 Added 9.96%	5,520 $453,000
Q4 2021 Feb 01, 2022	BUY	$72.28 - $90.54 $34,333 - $43,006	475 Added 10.45%	5,020 $385,000
Q2 2021 Aug 02, 2021	BUY	$70.31 - $77.77 $84,372 - $93,324	1,200 Added 35.87%	4,545 $353,000
Q1 2021 Apr 30, 2021	BUY	$68.86 - $81.11 $69,824 - $82,245	1,014 Added 43.5%	3,345 $258,000
Q4 2020 Jan 29, 2021	SELL	$71.77 - $79.65 $45,286 - $50,259	-631 Reduced 21.3%	2,331 $191,000
Q2 2020 Aug 07, 2020	SELL	$70.42 - $80.13 $14,084 - $16,026	-200 Reduced 6.33%	2,962 $229,000
Q1 2020 May 01, 2020	SELL	$63.36 - $87.82 $12,672 - $17,564	-200 Reduced 5.95%	3,162 $243,000
Q4 2019 Jan 21, 2020	BUY	$77.58 - $87.54 $8,533 - $9,629	110 Added 3.38%	3,362 $306,000
Q4 2018 Feb 08, 2019	BUY	$65.24 - $75.71 $42,406 - $49,211	650 Added 24.98%	3,252 $248,000
Q3 2018 Nov 05, 2018	SELL	$57.69 - $67.84 $2,884 - $3,392	-50 Reduced 1.89%	2,602 $185,000
Q2 2018 Aug 06, 2018	BUY	$50.83 - $59.72 $8,386 - $9,853	165 Added 6.63%	2,652 $161,000
Q1 2018 May 04, 2018	BUY	$50.96 - $59.23 $509 - $592	10 Added 0.4%	2,487 $135,000
Q3 2017 Nov 03, 2017	BUY	$58.67 - $63.13 $58 - $63	1 Added 0.04%	2,477 $159,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,476	2,476 $159,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account